These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 4216180)

  • 21. Preservation of the ischemic myocardium: a review of new concepts in the treatment of acute myocardial infarction and unstable angina.
    Medd WL
    J Maine Med Assoc; 1977 Apr; 68(4):118-22, 131. PubMed ID: 403246
    [No Abstract]   [Full Text] [Related]  

  • 22. [Combination therapy of angina pectoris vera with coronary active substances and Faustan].
    Nossing R; Gruber G; Schmidt P
    Z Arztl Fortbild (Jena); 1971 Jun; 65(12):589-91. PubMed ID: 5000186
    [No Abstract]   [Full Text] [Related]  

  • 23. New dimension in angina pectoris therapy.
    Russek HI
    Geriatrics; 1969 Mar; 24(3):81-95. PubMed ID: 4885554
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 25. [Coronary therapy with Nitro-Sandolanid].
    Toker Y
    Munch Med Wochenschr; 1970 Apr; 112(17):809-12. PubMed ID: 5467991
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of the antianginal action of pharmacological substances by the change in the initiation threshold for myocardial ischemia in conscious rabbits].
    Rozonov IuB; Morozova TV
    Biull Eksp Biol Med; 1984 Oct; 98(10):460-2. PubMed ID: 6437458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of nitroglycerin on myocardial ischemia and its clinical manifestations in severe coronary heart disease.
    Amsterdam EA; Laslett L; Rutledge JC; Zakauddin V
    Bibl Cardiol; 1985; (39):118-28. PubMed ID: 3939511
    [No Abstract]   [Full Text] [Related]  

  • 28. [Actihaemyl as adjuvant in cardiac therapy].
    Lordick H
    Munch Med Wochenschr; 1970 Feb; 112(7):298-300. PubMed ID: 5537795
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
    Gatti A; Scotti G
    Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
    [No Abstract]   [Full Text] [Related]  

  • 30. [Atherosclerosis progression and standard in coronary disease. Nitrate with special talents: PETN (pentaerythritol tetranitrate) is vasoprotective].
    MMW Fortschr Med; 2002 Nov; 144(45):51. PubMed ID: 12534064
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical use of a combination of butydrine and pentaerythrol in coronary insufficiency].
    Ballerini A
    Minerva Cardioangiol; 1971 May; 19(5):272-6. PubMed ID: 4397515
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the circulatory effect of the coronary dilator PETN].
    Tilsner V
    Med Klin; 1969 Jun; 64(24):1120-3. PubMed ID: 5809489
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathophysiology and medical management of angina pectoris.
    Gottlieb RS; Duca PR; Brest AN
    Am Fam Physician; 1977 Oct; 16(4):82-9. PubMed ID: 410283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of propranolol in the long-term treatment of angina pectoris.
    Zeft HJ; Patterson S; Orgain ES
    Arch Intern Med; 1969 Nov; 124(5):578-83. PubMed ID: 4981283
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study of the treatment of angina pectoris with nitrong, papaverine, erinit and euphylline].
    Volkov VS; Bratoliubov VP
    Sov Med; 1985; (7):77-80. PubMed ID: 3934766
    [No Abstract]   [Full Text] [Related]  

  • 36. [Continuous protection against angina pectoris-like disorders. Attack prevention without a nitrate pause].
    MMW Fortschr Med; 2003 Sep; 145(39):54. PubMed ID: 14649081
    [No Abstract]   [Full Text] [Related]  

  • 37. [The hemodynamic profile of pentaerythrityl tetranitrate].
    Engelmann L; Gottschild D
    Z Gesamte Inn Med; 1981 Apr; 36(7):244-6. PubMed ID: 7281826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical experiences with a combined preparation (butydrine and pentaerythritol tetranitrate) in coronary insufficiency].
    Chiti E
    Clin Ter; 1970 May; 53(4):315-21. PubMed ID: 4394192
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy with pentaerithrityltetranitrate (PETN). Established effectiveness, once again on trial].
    MMW Fortschr Med; 2011 Feb; 153(7):44-5. PubMed ID: 21648143
    [No Abstract]   [Full Text] [Related]  

  • 40. [Longtern therapy of coronary failure].
    Meesmann W
    Munch Med Wochenschr; 1968 Apr; 110(17):1066-73. PubMed ID: 4974159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.